Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Skybridge to acquire Citi hedge fund business, will make SkyBridge a $5.6bn firm

Wednesday, April 14, 2010
Opalesque Industry Updates - Citigroup Inc. said it will sell its hedge-fund business to alternative-investment firm SkyBridge Capital LLC, as it sheds yet another of its noncore assets.

Financial terms of the deal, in which SkyBridge will buy Citi Alternative Investments' hedge-fund, hedge-fund seeding and hedge-fund advisory businesses, weren't disclosed. CAI's investments under management and advisory total $4.2 billion. SkyBridge said the deal will position it as "one of the leading global alternative asset managers" with $5.6 billion in assets under management.

The businesses being acquired are part of Citi Holdings, which is made up of Citi's noncore assets and businesses that the financial-services giant is in the process of unloading. Citi's Raymond Nolte, who has led the businesses at CAI since 2005, will become chief investment officer and a managing partner at SkyBridge, bringing with him a team of 20.

"The integration of a fund-of-hedge-funds business is a natural fit with the SkyBridge platform, and this deal is a result of our long-term strategy to acquire assets that maximize value for investors," said Skybridge Managing Partner Anthony Scaramucci.

Citi last year earmarked $715 billion in noncore assets to be sold, liquidated or wound down as it sought to reduce its risk profile during the market meltdown that saw the U.S. government take a roughly one-quarter ownership stake currently at 27%. Roughly one-quarter of those assets had been shed by the end of 2009.

Shares of Citigroup rose 2.2% to $4.72 in recent premarket trading amid the release of strong first-quarter results from rival J.P. Morgan Chase & Co.

Corporate website: Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for